[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH0421637A - High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production - Google Patents

High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production

Info

Publication number
JPH0421637A
JPH0421637A JP2122459A JP12245990A JPH0421637A JP H0421637 A JPH0421637 A JP H0421637A JP 2122459 A JP2122459 A JP 2122459A JP 12245990 A JP12245990 A JP 12245990A JP H0421637 A JPH0421637 A JP H0421637A
Authority
JP
Japan
Prior art keywords
chitin
chitosan
latex
high polymer
polymer fine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2122459A
Other languages
Japanese (ja)
Inventor
Shunichi Morikawa
俊一 森川
Katsuhiro Hanada
花田 克裕
Kiyotaka Takemoto
竹本 清孝
Takaaki Arai
新井 孝昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Soken Kagaku KK
Original Assignee
Soken Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soken Kagaku KK filed Critical Soken Kagaku KK
Priority to JP2122459A priority Critical patent/JPH0421637A/en
Publication of JPH0421637A publication Critical patent/JPH0421637A/en
Pending legal-status Critical Current

Links

Landscapes

  • Processes Of Treating Macromolecular Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE:To obtain high polymer fine grains having a hydrophilic and positively ionized surface and improved in affinity to a biological high polymer by modifying the surface of high polymer fine grains with a chitin derivative or chitosan. CONSTITUTION:High polymer fine grains having an active groups reactive with a carbodiimide compound, preferably a carboxyl latex having 0.2-10mum grain size is made to react with a compound expressed by the formula RN=C= NR' (R is ethyl and R' is dimethylaminopropyl or R and R' are cyclohexyl together) at ordinary temperature and successively subjected to a reaction with a chitin derivative (preferably diethylaminoethylchitin) or chitosan added at ordinary temperature. The resultant modified high polymer fine grains are used as a latex for immobilization of bioaffinitive ingredient, physiologically active substance and medicine, etc., latex for immunodiagnostic agent and endotoxin removing agent.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、蛋白質、核酸等の生体成分の分離精製に使用
されるクロマトグラフィーの吸着材、ドラッグ・デリバ
リ−・システム用担持体、免疫診断用ラテックスなどに
有用なキチン質又はキトサンを表面に修飾させた高分子
微粒子並びにその製造方法に関する。
[Detailed Description of the Invention] [Industrial Application Field] The present invention is applicable to chromatography adsorbents used for the separation and purification of biological components such as proteins and nucleic acids, carriers for drug delivery systems, and immunodiagnosis. The present invention relates to polymer particles whose surfaces are modified with chitin or chitosan, which are useful for latex, etc., and a method for producing the same.

〔従来の技術〕[Conventional technology]

従来、抗原抗体反応を利用した免疫学的臨床検査診断薬
に疎水性表面を有するポリスチレンラテックスが用いら
れている(JColloid LnterfaceSc
i、、 71.350 (1979)。
Conventionally, polystyrene latex with a hydrophobic surface has been used for diagnostic reagents for immunological clinical tests that utilize antigen-antibody reactions (JColloid LnterfaceSc
i, 71.350 (1979).

しかし、ポリスチレンラテックスは疎水性であるため、
感作安定性、保存安定性が欠けるため、疎水性を改質す
るためスチレンにメタクリル酸等を共重合させた微粒子
高分子の研究、開発も行われている。
However, since polystyrene latex is hydrophobic,
Because of the lack of sensitization stability and storage stability, research and development are also being conducted on particulate polymers made by copolymerizing styrene with methacrylic acid, etc., in order to modify the hydrophobicity.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

上記スチレンラテックスにおいては、感作安定性、保存
安定性に欠け、またメタクリル酸等を共重合させたスチ
レン系ラテックスでもその感作安定性、保存安定性が十
分でないばかりでなく、これらスチレン系ラテックスに
おいては非特異的な凝集反応を有し、抗原或は抗体を固
定化した免疫学的血清、血漿、尿等の高感度、定量分析
用ラテックスとしては満足するものではない。
The above-mentioned styrene latex lacks sensitization stability and storage stability, and even styrene latex copolymerized with methacrylic acid etc. not only has insufficient sensitization stability and storage stability; It has a non-specific agglutination reaction and is not satisfactory as a latex for highly sensitive and quantitative analysis of immunological serum, plasma, urine, etc. on which antigens or antibodies are immobilized.

本発明はラテックスを親水性に改良し、更に好適には正
荷電性へ変換させて動物細胞、免疫蛋白質等の生体高分
子に対する親和性を向上させ蛋白質、核酸等の生体成分
に特異的な吸着性を有し、ドラッグ・デリバリ−・シス
テム用担持体、免疫診断用ラテックス等として有用な高
分子微粒子並びにその製造方法を提供することを目的と
するものである。
The present invention improves latex to be hydrophilic, and more preferably converts it to positively charged property to improve its affinity for biopolymers such as animal cells and immune proteins, and to specifically adsorb latex to biocomponents such as proteins and nucleic acids. The object of the present invention is to provide polymeric microparticles that have properties and are useful as carriers for drug delivery systems, latex for immunodiagnosis, etc., and a method for producing the same.

〔課題を解決するための手段〕[Means to solve the problem]

本発明等はバイオアフィニティー成分、生理活性物質、
薬剤などの固定、免疫学的臨床検査診断薬、エンドトキ
シン除去剤として使用される高分子微粒子を開発する目
的で蛋白質、酵素等の生体高分子に対して選択的な吸着
性及び親和性を有するキチンの構成単位であるグルコサ
ミンを有し、しかも好ましくは正荷電をも有するキチン
誘導体並びにキトサンを高分子微粒子の表面に修飾させ
てドラッグ・デリバリ−・システム用担持体、免疫診断
薬用ラテックス等に極めて使用し易い高分子微粒子形態
で提供し得ること並びにそのキチン誘導体、キトサンの
高分子物への修飾方法を見出し本発明を完成した。
The present invention etc. are bioaffinity components, physiologically active substances,
Chitin, which has selective adsorption and affinity for biopolymers such as proteins and enzymes, is used for the purpose of developing polymeric microparticles used as immobilization of drugs, diagnostic agents for immunological clinical tests, and endotoxin removal agents. Chitin derivatives and chitosan, which have glucosamine as a constituent unit and preferably also have a positive charge, can be modified on the surface of polymeric particles and used as carriers for drug delivery systems, latex for immunodiagnostic agents, etc. The present invention was completed by discovering that chitin derivatives and chitosan can be easily provided in the form of fine polymer particles, and a method for modifying chitin derivatives and chitosan into polymers.

本発明は、キチン誘導体又はキトサンを表面に修飾した
高分子微粒子である。そしてカルボキシルラテックス微
粒子を式 RN=C=NR’ (式中Rはエチル基、R′はジメチ
ルアミノプロピル基又はR,R’は共にシクロヘキシル
基を示す)で表わされるカルボジイミド化合物と反応さ
せ、次いでキチン誘導体又はキトサンを反応させること
を特徴とするキチン誘導体又はキトサンを表面に修飾し
た高分子微粒子の製造方法である。
The present invention is a polymer fine particle whose surface is modified with a chitin derivative or chitosan. Then, the carboxyl latex fine particles are reacted with a carbodiimide compound represented by the formula RN=C=NR' (wherein R is an ethyl group, R' is a dimethylaminopropyl group, or both R and R' are a cyclohexyl group), and then chitin This is a method for producing polymer fine particles whose surface is modified with a chitin derivative or chitosan, which is characterized by reacting the derivative or chitosan.

本発明に使用する高分子微粒子はカルボジイミド化合物
と反応する活性基を有する高分子化合物であり、カルボ
キシルラテックスが好適である。そしてその粒径は製品
の用途により適宜選択されるが、大体0.2〜10μm
が普通使用される。
The polymer fine particles used in the present invention are polymer compounds having an active group that reacts with a carbodiimide compound, and carboxyl latex is preferable. The particle size is selected appropriately depending on the application of the product, but it is approximately 0.2 to 10 μm.
is commonly used.

この高分子微粒子に修飾されるキチン誘導体としては、
水溶性のキチン誘導体、例えば、ジエチルアミノエチル
キチン、カルボキシメチルキチン、ヒドロキシプロピル
キチン、ヒドロキシエチルキチン、硫酸エステルキチン
、リン酸エステルキチン等が好適に用いられ、本発明者
等が先に発表したジエチルアミノエチルキチン[Pol
ymer Bulletin、 21.13−17(1
989) Eが最も適している。キトサンもキチンを脱
アセチル化したものでキチンの構成単位であるグルコサ
ミンを有し、しかも正電荷を有する物質であり、本発明
に好適に適用できる。
The chitin derivatives modified into these polymer particles include:
Water-soluble chitin derivatives such as diethylaminoethyl chitin, carboxymethyl chitin, hydroxypropyl chitin, hydroxyethyl chitin, sulfate ester chitin, phosphate ester chitin, etc. are preferably used, and the diethylaminoethyl chitin previously announced by the present inventors Chitin [Pol
ymer Bulletin, 21.13-17 (1
989) E is the most suitable. Chitosan is also a substance obtained by deacetylating chitin, contains glucosamine, which is a constituent unit of chitin, and is a positively charged substance, and can be suitably applied to the present invention.

以上のように、本発明の高分子微粒子は表面にキチン誘
導体又はキトサンを修飾したものであるから、表面が正
電荷性及び親水性を有する微粒子と改質され、微粒子で
あるため表面積が犬で、しかも表面の電荷密度が高くそ
の表面活性を利用して各種の蛋白質、酵素などの生体高
分子の吸着、脱着及び抗原又は抗体を固定化するイムノ
ミクロスファアによる診断剤として有用に使用できると
共に、医薬品の副作用原因の一つである発熱物質エンド
トキシンを選択的に吸着除去剤としての用途も期待され
る。また保水性を利用し整髪剤などの化粧品成分材料と
しても使用できる極めて有用なものである。
As described above, the polymer particles of the present invention have surfaces modified with chitin derivatives or chitosan, so the surfaces are modified to have positively charged and hydrophilic properties, and because they are fine particles, the surface area is small. In addition, the surface charge density is high, and by utilizing the surface activity, it can be usefully used as a diagnostic agent by adsorbing and desorbing biopolymers such as various proteins and enzymes, and by immobilizing antigens or antibodies. It is also expected to be used as a selective adsorbent and remover for endotoxin, a pyrogenic substance that is one of the causes of side effects of pharmaceuticals. Moreover, it is extremely useful because it can be used as a cosmetic component material such as a hair styling agent due to its water-retaining properties.

上記キチン誘導体又はキトサンを有する高分子微粒子を
製造するには、カルボキシル基などの活性基を有する高
分子微粒子、好適にはカルボキシルラテックス、この物
質は例えば、スチレンモノマーを単独で重合させ核粒子
とした後、アクリルアミドを添加し、2段重合法により
精製したスチレン−アクリルアミド共重合ラテックスを
加水分解することにより得られる。
In order to produce the above-mentioned polymer fine particles having a chitin derivative or chitosan, polymer fine particles having an active group such as a carboxyl group, preferably carboxyl latex, are used, and this material is made by polymerizing, for example, a styrene monomer alone and forming a core particle. Thereafter, acrylamide is added and the styrene-acrylamide copolymer latex purified by a two-stage polymerization method is hydrolyzed.

この高分子微粒子に水を媒体として水溶性の一般式RN
=C=NR’  (式中、R,R’は前記と同一意義を
有す。)で表わされるカルボジイミド化合物、1−エチ
ル−5−(3−ジメチルアミノプロピル)カルボジイミ
ド、1.3−ジシクロへキシルカルボジイミドを常温で
反応させ、次にチキン誘導体又はキトサンを加え約12
時間位常温で反応すると本発明のキチン誘導体又はキト
サンを表面に修飾した高分子微粒子が得られる。
The water-soluble general formula RN
=C=NR' (wherein R, R' have the same meanings as above), a carbodiimide compound, 1-ethyl-5-(3-dimethylaminopropyl)carbodiimide, 1,3-dicyclo React xylcarbodiimide at room temperature, then add chicken derivative or chitosan for about 12 hours.
When the reaction is carried out at room temperature for about a period of time, polymer fine particles whose surfaces are modified with the chitin derivative or chitosan of the present invention are obtained.

本方法におけるキチン誘導体及びキトサンの使用量は高
分子のカルボキシル基に対し、キチン誘導体又はキトサ
ンのアミノ基として1〜8倍モル量が適当であり、4〜
8倍モル量が好適である。又、水溶性カルボジイミド化
合物の使用量は、キチン誘導体又はキトサンのアミノ基
に対し0.5〜1.5倍モル量が適当であり、好適には
0.8〜1.2倍モル量である。
The appropriate amount of the chitin derivative and chitosan used in this method is 1 to 8 times the molar amount of the amino group of the chitin derivative or chitosan relative to the carboxyl group of the polymer, and 4 to 8 times the molar amount of the amino group of the chitin derivative or chitosan.
An 8-fold molar amount is preferred. Further, the amount of water-soluble carbodiimide compound to be used is suitably 0.5 to 1.5 times the molar amount, preferably 0.8 to 1.2 times the molar amount of the amino group of the chitin derivative or chitosan. .

次に本発明の微粒子の製造法並びに得られた物質の性質
を記載する。
Next, the method for producing the fine particles of the present invention and the properties of the obtained materials will be described.

〔実施例〕〔Example〕

例  1 表面電荷量89.5μ当量/g・ラテックス、粒径0.
6μm、比表面積10rri/g・ラテックスのカルボ
キシルラテックスの分散液(濃度0.0157g/mf
f) 400dに1−エチル−3−(3−ジメチルアミ
ノプロピル)カルボジイミド塩酸塩0.0108gを加
え、室温で2時間撹拌する。次いで1%ジエチルアミノ
エチルキチン水溶液63g(ラテックス中のカルボキシ
ル基に対してジエチルアミノエチルキチンのアミン基と
して2倍モル量)を加え、12時間反応させ、次いで2
M酢酸緩衝液(PH= 4 )を加えて2時間撹拌し得
られた生成物を決別する。その復水で洗浄し、減圧乾燥
しジエチルアミノエチルキチン修飾ラテックス0.68
 gを得た。このものの表面荷電量は24.6μ当量/
g・ラテックスであった。また、得られたラテックスの
接触角(θ)は26.4であった。なお表面荷電量はコ
ロイド滴定により測定し、接触角は自動式PHW型接触
角計で測定した。
Example 1 Surface charge: 89.5μ equivalent/g latex, particle size: 0.
Carboxyl latex dispersion with a specific surface area of 10 rri/g/latex (concentration 0.0157 g/mf)
f) Add 0.0108 g of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride to 400 d and stir at room temperature for 2 hours. Next, 63 g of a 1% diethylaminoethyl chitin aqueous solution (twice the molar amount as the amine group of diethylaminoethyl chitin relative to the carboxyl group in the latex) was added, and the mixture was reacted for 12 hours.
Add M acetate buffer (PH=4), stir for 2 hours, and separate the resulting product. Washed with condensed water and dried under reduced pressure to obtain diethylaminoethyl chitin modified latex 0.68
I got g. The surface charge amount of this material is 24.6μ equivalent/
g. It was latex. Further, the contact angle (θ) of the obtained latex was 26.4. Note that the surface charge amount was measured by colloid titration, and the contact angle was measured using an automatic PHW type contact angle meter.

例2〜3 1−エチル−5−(3−ジメチルアミノプロピル)カル
ボジイミド塩酸塩(WSC)及び1%ジエチルアミノエ
チルキチン水溶液(DEAE−キチン水溶液)を第1表
に示す量加えた以外は例1と同様の操作を行い、DEA
E−キチン修飾ラテックスを得た。この例の収量、表面
荷電量及び接触角は第1表の通りであった。なお、1%
DEAE−キチン量はラテックス中のカルボキシル基に
対してDEAE−キチンのアミン基として4倍乃至8倍
モル量である。
Examples 2-3 Same as Example 1 except that 1-ethyl-5-(3-dimethylaminopropyl)carbodiimide hydrochloride (WSC) and 1% diethylaminoethyl chitin aqueous solution (DEAE-chitin aqueous solution) were added in the amounts shown in Table 1. Perform the same operation and DEA
E-chitin modified latex was obtained. The yield, surface charge amount, and contact angle of this example were as shown in Table 1. In addition, 1%
The amount of DEAE-chitin is 4 to 8 times the molar amount of the amine group of DEAE-chitin relative to the carboxyl group in the latex.

第 表 例4〜6 1%DEAE−キチン水溶液を1%キトサン水溶液に代
え、WSC及び1%キトサン水溶液量を第2表に示す量
を加えた以外は実施例1と同様の操作を行い、キトサン
修飾ラテックスを得た。この例の収量、表面荷電量及び
接触角は第2表の通りであった。なお、1%キトサン水
溶液量はラテックス中のカルボキシル基に対してキトサ
ンのアミノ基として2倍乃至8倍モル量である。
Table Examples 4 to 6 The same operation as in Example 1 was performed except that the 1% DEAE-chitin aqueous solution was replaced with a 1% chitosan aqueous solution and the amounts of WSC and 1% chitosan aqueous solution shown in Table 2 were added. Obtained modified latex. The yield, surface charge amount, and contact angle of this example were as shown in Table 2. The amount of the 1% chitosan aqueous solution is 2 to 8 times the molar amount of the amino groups of chitosan relative to the carboxyl groups in the latex.

以下余白 第 表 例  7 表面荷電量38.5μ当量/g・ラテックス、濃度0.
0175 g /dのカルボキシルラテックス水分散液
40−を用い、WSC000052g、1%DEAE−
キチン水溶液3.Og (ラテックス中のカルボキシル
基に対してDEAE−キチンのアミノ基として2倍モル
量)加えた以外は、実施例1と同様の操作を行い、DE
AE−キチン修飾ラテックス0.81gを得た。このも
のの表面荷電量は21.6μ当量/g・ラテックスであ
った。
Below is an example of the table in the margin 7 Surface charge amount 38.5μ equivalent/g latex, concentration 0.
Using carboxyl latex aqueous dispersion 40-0175 g/d, WSC000052 g, 1% DEAE-
Chitin aqueous solution 3. The same operation as in Example 1 was carried out except that Og (twice the molar amount as the amino group of DEAE-chitin relative to the carboxyl group in the latex) was added.
0.81 g of AE-chitin modified latex was obtained. The surface charge amount of this product was 21.6 μequivalent/g·latex.

例  8 1%DEAE−キチン水溶液を1%キトサン水溶液1.
1g (ラテックス中のカルボキシル基に対してキトサ
ンのアミノ基として2倍モル量)に代えた以外は、例7
と同様の操作を行い、キトサン修飾ラテックス0.97
gを得た。このものの表面荷電量は4.3μ当量/g・
ラテックスであった。
Example 8 1% DEAE-chitin aqueous solution and 1% chitosan aqueous solution 1.
Example 7 except that 1 g (twice the molar amount of the amino group of chitosan relative to the carboxyl group in the latex)
Perform the same operation as above to obtain chitosan-modified latex 0.97
I got g. The surface charge amount of this material is 4.3μ equivalent/g・
It was latex.

〔発明の劾果〕[Results of invention]

本発明は微粒子上に親水性好ましくは更に正荷電をも有
するキチンの構成単体を持つ物質を修飾した微粒子であ
り、これにより生体高分子に対する特異の親和性を有す
るためバイオアフィニティー成分、生理活性物質、薬剤
などの固定、免疫診断薬用ラテックス、エンドトキシン
除去剤として極めて広範囲の用途を有する物質を提供す
る有用な発明である。
The present invention is a microparticle modified with a substance having a hydrophilic, preferably positively charged constituent element of chitin on the microparticle, which has a specific affinity for biopolymers and is therefore a bioaffinity component and a physiologically active substance. This is a useful invention that provides a substance that has an extremely wide range of uses, such as fixation of drugs, latex for immunodiagnostics, and endotoxin removal agent.

Claims (1)

【特許請求の範囲】 1、キチン誘導体又はキトサンを表面に修飾した高分子
微粒子。 2、キチン誘導体がジエチルアミノエチルキチンである
請求項1記載の高分子微粒子。 3、高分子微粒子がカルボキシルラテックスである請求
項1記載の高分子微粒子。 4、カルボキシルラテックス微粒子に式RN=C=NR
′(式中Rはエチル基、R′はジメチルアミノプロピル
基又はR、R′は共にシクロヘキシル基を示す)を有す
るカルボジイミド化合物を反応させ、次いでキチン誘導
体又はキトサンを反応させることを特徴とするキチン誘
導体又はキトサンを表面に修飾した高分子微粒子の製造
方法。 5、キチン誘導体がジエチルアミノエチルキチンである
請求項4記載の高分子微粒子の製法。
[Scope of Claims] 1. Polymer fine particles whose surface is modified with a chitin derivative or chitosan. 2. The polymer fine particles according to claim 1, wherein the chitin derivative is diethylaminoethyl chitin. 3. The polymeric fine particles according to claim 1, wherein the polymeric fine particles are carboxyl latex. 4. Carboxyl latex fine particles have the formula RN=C=NR
' (in the formula, R is an ethyl group, R' is a dimethylaminopropyl group, or both R and R' are a cyclohexyl group), and then a chitin derivative or chitosan is reacted. A method for producing polymer fine particles whose surfaces are modified with a derivative or chitosan. 5. The method for producing fine polymer particles according to claim 4, wherein the chitin derivative is diethylaminoethyl chitin.
JP2122459A 1990-05-11 1990-05-11 High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production Pending JPH0421637A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2122459A JPH0421637A (en) 1990-05-11 1990-05-11 High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2122459A JPH0421637A (en) 1990-05-11 1990-05-11 High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production

Publications (1)

Publication Number Publication Date
JPH0421637A true JPH0421637A (en) 1992-01-24

Family

ID=14836382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2122459A Pending JPH0421637A (en) 1990-05-11 1990-05-11 High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production

Country Status (1)

Country Link
JP (1) JPH0421637A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07216256A (en) * 1994-01-28 1995-08-15 Suzuki Yushi Kogyo Kk Colored fine particle and its production
EP0747703A2 (en) * 1995-06-09 1996-12-11 Nisshinbo Industries, Inc. Method for analyzing biological active substances
WO2004014988A1 (en) * 2002-08-09 2004-02-19 Nisshinbo Industries, Inc. Composite particle having carbodiimide resin layer and process for producing the same
WO2006123686A1 (en) * 2005-05-20 2006-11-23 Jsr Corporation Support polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same
JP2006321932A (en) * 2005-05-20 2006-11-30 Jsr Corp Carrier polymer particle and its production method
JP2007145985A (en) * 2005-11-28 2007-06-14 Jsr Corp Method for producing support polymer particle
JP2008514424A (en) * 2004-10-01 2008-05-08 スリーエム イノベイティブ プロパティズ カンパニー Composite filtration article
US7387832B2 (en) 2002-09-19 2008-06-17 Nisshinbo Industries, Inc. Flat particles and process for production thereof
JP4272811B2 (en) * 1997-09-05 2009-06-03 マルホ株式会社 Nanocapsule formulation for the treatment of intra-articular disease
KR20180122188A (en) * 2017-05-02 2018-11-12 포항공과대학교 산학협력단 Nahochitin-nanochitosan complex body, network structure body comprising thereof and manufacturing methods thereof, respectively
WO2020129404A1 (en) * 2018-12-17 2020-06-25 パナソニックIpマネジメント株式会社 Modified particle, method for producing modified particle, and detection device

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07216256A (en) * 1994-01-28 1995-08-15 Suzuki Yushi Kogyo Kk Colored fine particle and its production
EP0747703A2 (en) * 1995-06-09 1996-12-11 Nisshinbo Industries, Inc. Method for analyzing biological active substances
EP0747703A3 (en) * 1995-06-09 1998-09-09 Nisshinbo Industries, Inc. Method for analyzing biological active substances
JP4272811B2 (en) * 1997-09-05 2009-06-03 マルホ株式会社 Nanocapsule formulation for the treatment of intra-articular disease
WO2004014988A1 (en) * 2002-08-09 2004-02-19 Nisshinbo Industries, Inc. Composite particle having carbodiimide resin layer and process for producing the same
US7258921B2 (en) 2002-08-09 2007-08-21 Nisshinbo Industries, Inc. Composite particle with a carbodiimide resin layer and a process for producing the same
US7387832B2 (en) 2002-09-19 2008-06-17 Nisshinbo Industries, Inc. Flat particles and process for production thereof
JP2008514424A (en) * 2004-10-01 2008-05-08 スリーエム イノベイティブ プロパティズ カンパニー Composite filtration article
WO2006123686A1 (en) * 2005-05-20 2006-11-23 Jsr Corporation Support polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same
JP2006321932A (en) * 2005-05-20 2006-11-30 Jsr Corp Carrier polymer particle and its production method
US9447232B2 (en) 2005-05-20 2016-09-20 Jsr Corporation Carrier polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same
JP2007145985A (en) * 2005-11-28 2007-06-14 Jsr Corp Method for producing support polymer particle
KR20180122188A (en) * 2017-05-02 2018-11-12 포항공과대학교 산학협력단 Nahochitin-nanochitosan complex body, network structure body comprising thereof and manufacturing methods thereof, respectively
WO2020129404A1 (en) * 2018-12-17 2020-06-25 パナソニックIpマネジメント株式会社 Modified particle, method for producing modified particle, and detection device
CN112166315A (en) * 2018-12-17 2021-01-01 松下知识产权经营株式会社 Modified particle, method for producing modified particle, and detection device
JPWO2020129404A1 (en) * 2018-12-17 2021-11-04 パナソニックIpマネジメント株式会社 Modified particles, method for producing modified particles, and detection device

Similar Documents

Publication Publication Date Title
US7582488B2 (en) Gel-shell beads with adsorbed or bound biomolecules
JPS6315551B2 (en)
JPH0723893B2 (en) Antibody immobilization method
JPH04339808A (en) Bioactive reagent produced from carboxylated polymer, analytical element, and method for use
JP2005526226A (en) Method for producing fine particles loaded with protein
JPS5896616A (en) Latex, biologically active latex conjugate and manufacture
JPS60142259A (en) Immobilized antibody
JPH0421637A (en) High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production
US20090253220A1 (en) Absorbing Biomolecules into Gel-Shell Beads
JPS6048524B2 (en) Biologically active substance reagent and its manufacturing method
US6262256B1 (en) Article for tuesyl-activated dextran for solid-phase coupling
Sarobe et al. Functionalized monodisperse particles with chloromethyl groups for the covalent coupling of proteins
FI60319C (en) FOERFARANDE FOER PAOVISNING ELLER BESTAEMNING AV ANTIKROPPAR I KROPPSVAETSKOR MED HJAELP AV KAENDA ANTIGENER ELLER FOER BESTTAEMNING AV ANTIGENER MED HJAELP AV KAENDA ANTIKROPPAR FRAON KROPPSVAETSKOR SAMT MED
EP0153763A2 (en) Affinity chromatography matrix with built-in reaction indicator
NZ544585A (en) Saquinavir mesylate oral dosage form
JPH073426B2 (en) Carrier of diagnostic agglutination reagent
WO1984003358A1 (en) Insoluble surfaces treated to inhibit non-specific protein binding
JP2545503B2 (en) Immunological diagnostic reagent
EP0569086A2 (en) Method and kit for attaching compounds to carboxylated substrates using uronium salt
JPH0454905B2 (en)
JPS6315553B2 (en)
JPH0431669B2 (en)
Hechemy et al. Coating of polymeric surfaces for immunoassay by a forced adsorption technique
JPS62231169A (en) Immunological diagnosing reagent
JPH0564741B2 (en)